Cellular metabolism regulates the fate decision between pathogenic and regulatory T cells
Wednesday, February 26, 2020 - 09:20
in Health & Medicine
Patients with autoimmune diseases like multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis have an imbalance between two types of immune system T cells. Destructive Th17 cells that mediate chronic inflammation are elevated, and regulatory T cells, or Treg cells, which suppress inflammatory responses and play a protective role in autoimmune disorders, are diminished.